Candel Therapeutics News

Candel Therapeutics | 10-Q: Quarterly report

May 14 20:34

Candel Therapeutics | 8-K: Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

May 14 20:19

Candel Therapeutics | 8-K: Current report

Apr 25 20:34

Candel Therapeutics | 10-K/A: Annual report (Amendment)

Apr 25 19:35

Candel Therapeutics | 8-K: Current report

Apr 11 21:04

Candel Therapeutics | 8-K: Current report

Apr 9 20:34

Candel Therapeutics | 8-K: Current report

Apr 4 20:35

Candel Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 28 20:19

Candel Therapeutics | 10-K: Annual report

Mar 28 20:05

Candel Therapeutics | 8-K: Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

Mar 28 19:49

Candel Therapeutics | 8-K: Current report

Mar 6 21:03

Candel Therapeutics | 424B5: Prospectus

Feb 13 22:04

Candel Therapeutics | 8-K: Current report

Feb 13 20:49

Candel Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Schoch Charles

Jan 19 13:00

Candel Therapeutics | 8-K: Current report

Jan 12 13:00

Candel Therapeutics | 8-K: Current report

Jan 3 13:00

Candel Therapeutics | 8-K: Current report

Dec 15, 2023 07:33

Candel Therapeutics | 8-K: Current report

Dec 12, 2023 21:30

Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Tyagarajan Seshu

Dec 1, 2023 06:00

Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Tak Paul Peter

Dec 1, 2023 06:00